AMYRIS TO PRESENT AT THE 42nd ANNUAL COWEN HEALTH CARE CONFERENCE

Amyris, a leading synthetic biotechnology company, announced its participation in a fireside chat at the 42nd Annual Cowen Health Care Conference on March 7, 2022, at 1:30 pm ET.

Rhea-AI Summary

Amyris, a leading synthetic biotechnology company, announced its participation in a fireside chat at the 42nd Annual Cowen Health Care Conference on March 7, 2022, at 1:30 pm ET. The event will focus on the company's Lab-to-Market™ technology platform, which drives sustainable consumption in the Clean Health & Beauty and Flavors & Fragrances sectors. A live webcast of the presentation and a replay will be available on the company's Investor Relations website. Amyris products reach over 300 million consumers and are featured in more than 20,000 items worldwide.

Argus Session date unavailable

-1.08% session move Open Argus

Details

News Market Reaction – AMRS

The recorded move for AMRS in the trading session of this news was -1.08%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EMERYVILLE, Calif., Feb. 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that management will participate in a fireside chat at the 42^nd Annual Cowen Health Care Conference on Monday, March 7, 2022, at 1:30 pm ET.

A live webcast of the presentation and a replay will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.

About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ technology platform. This Amyris technology platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com.

Amyris, the Amyris logo and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.

 

View original content:https://www.prnewswire.com/news-releases/amyris-to-present-at-the-42nd-annual-cowen-health-care-conference-301491274.html

SOURCE Amyris, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Amyris presenting at the Cowen Health Care Conference?

Amyris will present at the Cowen Health Care Conference on March 7, 2022, at 1:30 pm ET.

What is the focus of Amyris's presentation at the conference?

The focus will be on Amyris's Lab-to-Market™ technology platform and its impact on sustainable consumption.

Where can I watch the Amyris conference presentation?

The presentation will be available via a live webcast on the Investor Relations section of Amyris's website.

What markets does Amyris operate in?

Amyris operates in the Clean Health & Beauty and Flavors & Fragrances markets, offering sustainable ingredients.

How many consumers do Amyris products reach?

Amyris products reach over 300 million consumers globally, included in more than 20,000 products.